{"DataElement":{"publicId":"3153663","version":"1","preferredName":"Patient Serious Concomitant Disease or Disorder Eligibility Determination Ind-2","preferredDefinition":"the yes/no indicator related to criteria to determine eligibility of patients for medical care programs and services based on serious concomitant illness.","longName":"3153662v1.0:2018257v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3153662","version":"1","preferredName":"Patient Serious Concomitant Disease or Disorder Eligibility Determination","preferredDefinition":"information related to criteria to determine eligibility of patients for medical care programs and services based on serious concomitant illness.","longName":"2177068v1.0:3153660v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177068","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"Patient","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7AB6-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3153660","version":"1","preferredName":"Serious Concomitant Disease or Disorder Eligibility Determination","preferredDefinition":"Causing fear or anxiety by threatening great harm; of great consequence.:Concomitant; following as a consequence.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Criteria to determine eligibility of patients for medical care programs and services.","longName":"C54035:C25730:C2991:C25171","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serious","conceptCode":"C54035","definition":"Causing fear or anxiety by threatening great harm; of great consequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Concomitant","conceptCode":"C25730","definition":"Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Eligibility Determination","conceptCode":"C25171","definition":"The act of determining if a subject is suitable for enrollment in a study according specific protocol criteria and procedures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B13CA2-3C39-5830-E040-BB89AD43068D","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-28","modifiedBy":"ONEDATA","dateModified":"2010-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93B13CA2-3C4A-5830-E040-BB89AD43068D","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104940","version":"1","longName":"GOG-0268","context":"NRG"},{"publicId":"4104898","version":"1","longName":"GOG-0258","context":"NRG"}]},{"publicId":"4254096","version":"1","longName":"Protocol Phase","context":"PBTC","ClassificationSchemeItems":[{"publicId":"10000103","version":"1","longName":"Phase I","context":"PBTC"},{"publicId":"4254119","version":"1","longName":"PBTC-042","context":"PBTC"}]}],"AlternateNames":[{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"3153662v1.0:2018257v1.0","type":"USED_BY","context":"NRG"},{"name":"TxyPclNxtTx","type":"COG GDE Short Name","context":"COG"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"SRUS_COMT_DZDR_IND","type":"OID, CCTG","context":"CCTG"},{"name":"3153662v1.0:2018257v1.0","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Does the patient have a serio","type":"Preferred Question Text","description":"Does the patient have a serious concomitant illness which, in the opinion of the treating physician, will place patient at unreasonable risk from therapy on this protocol?","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Does the patient have a history of serious co-morbid illness or uncontrolled illnesses that would preclude protocol therapy?","url":null,"context":"CTEP"},{"name":"PBTC_Text1","type":"Alternate Question Text","description":"Does the patient have clinically significant unrelated systemic illness that is likely to interfere with the study procedures or results?","url":null,"context":"PBTC"},{"name":"PBTC_Text2","type":"Alternate Question Text","description":"Does patient have any uncontrolled intercurrent illness including, but not limited to, acute or chronic liver, renal disease or pancreatitis, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements?","url":null,"context":"PBTC"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have residual severe non-hematologic toxicities from Block 1 therapy that are likely to  preclude  beginning next course of risk-assignment based therapy within required time frame?","url":null,"context":"COG"},{"name":"alt text","type":"Alternate Question Text","description":"Patient has any clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction), that in the opinion of the investigator would compromise the patient's ability to tolerate protocol therapy, or put them at additional risk for toxicity or would interfere with the study procedures or results?","url":null,"context":"PBTC"},{"name":"PBTC_Text4","type":"Alternate Question Text","description":"Patient has any clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction), that in the opinion of the investigator would compromise the patient's ability to tolerate protocol therapy, put them at additional risk for toxicity or would interfere with the study procedures, assessments, or results?","url":null,"context":"PBTC"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Does patient have any of the indicated diagnoses","url":null,"context":"COG"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"Does the patient have active, clinically serious infections > CTCAE Grade 2?","url":null,"context":"CTEP"},{"name":"PBTC_Text3","type":"Alternate Question Text","description":"Does the patient have any clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction), that in the opinion of the investigator would compromise the ability of the patient to tolerate protocol therapy, or put them at additional risk for toxicity or would interfere with the study procedures or results?","url":null,"context":"PBTC"},{"name":"MA39","type":"Alternate Question Text","description":"Patient has serious non-malignant disease (e.g. cardiovascular, scleroderma etc.) which would preclude RT.","url":null,"context":"CCTG"},{"name":"PBTC_Text5","type":"Alternate Question Text","description":"Does the patient have a known serious active infection including, but not limited to, viral hepatitis, human immunodeficiency virus, tuberculosis, or with any clinically significant unrelated systemic illness or significant cardiac, pulmonary, hepatic or other organ dysfunction, that in the opinion of the investigator would compromise the patient's ability to tolerate protocol therapy, put them at additional risk for toxicity or would interfere with the study procedures or results?","url":null,"context":"PBTC"},{"name":"NRG_CRF_TEXT1","type":"Alternate Question Text","description":"Does the patient have any other concomitant serious illness or organ system dysfunction that in the opinion of the investigator would either compromise patient safety or interfere with the evaluation of the safety of the study drug?","url":null,"context":"NRG"},{"name":"CRF TEXT 3","type":"Alternate Question Text","description":"Does the patient have severe pulmonary, cardiac, or other systemic disease","url":null,"context":"NRG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Has patient developed symptoms concerning for new systemic infection or condition that in the opinion of the treating physician may pose an unacceptable risk to the patient?","url":null,"context":"COG"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"93B13CA2-3C5C-5830-E040-BB89AD43068D","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-18","changeDescription":"Replaced VD Eligibility Ind-2 2018257v1 with VD ID#3506068 - Yes No Indicator - dbw","administrativeNotes":"2023.9.18 AQT added per ticket request CADSR0002860. ak","unresolvedIssues":null,"deletedIndicator":"No"}}